Detalhe da pesquisa
1.
Identification of 4 novel HLA-B*40:01 restricted minor histocompatibility antigens and their potential as targets for graft-versus-leukemia reactivity.
Haematologica
; 97(8): 1196-204, 2012 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-22419570
2.
Discovery and Differential Processing of HLA Class II-Restricted Minor Histocompatibility Antigen LB-PIP4K2A-1S and Its Allelic Variant by Asparagine Endopeptidase.
Front Immunol
; 11: 381, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32218783
3.
Enhanced engraftment of umbilical cord blood-derived stem cells in NOD/SCID mice by cotransplantation of a second unrelated cord blood unit.
Exp Hematol
; 33(10): 1249-56, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16219548
4.
Proteosomal degradation of BCR/ABL protein can generate an HLA-A*0301-restricted peptide, but high-avidity T cells recognizing this leukemia-specific antigen were not demonstrated.
Haematologica
; 89(9): 1062-71, 2004 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15377467
5.
High-throughput characterization of 10 new minor histocompatibility antigens by whole genome association scanning.
Cancer Res
; 70(22): 9073-83, 2010 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21062987
6.
Mesenchymal stem cells inhibit generation and function of both CD34+-derived and monocyte-derived dendritic cells.
J Immunol
; 177(4): 2080-7, 2006 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16887966
7.
Donor-derived mesenchymal stem cells are immunogenic in an allogeneic host and stimulate donor graft rejection in a nonmyeloablative setting.
Blood
; 108(6): 2114-20, 2006 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16690970